Decapeptyl: EUR 536M Key Peptide Products: Lanreotide (Somatuline somatostatin analogue for NETs, acromegaly), triptorelin (Decapeptyl GnRH agonist for prostate/breast cancer, endometriosis), abarelix (predecessor), cabozantinib (Cabometyx kinase inhibitor) Therapeutic Segments: Oncology (NETs, prostate cancer, breast cancer)
Trust SSP Research for high-quality BPC-157 research grade peptides to advance your studies
Personalized cancer vaccines: targeting the cancer mutanome
After sample concentration and washing, the trap columns were serially connected with an analytical C18 column (Thermo, 75 m 50 cm, particle size 2 m, pore size 100 ) and the peptides were separated with a flow rate of 400 nl/min using a solvent gradient of 4% to 40% B for 95 min that remained for 5 min and was then returned to 4% B